XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.26.1

STOCKHOLDERS' EQUITY | 9 Months Ended
--- | ---
Mar. 31, 2026
Equity [Abstract] |
STOCKHOLDERS' EQUITY | STOCKHOLDERS’ EQUITY Changes in the components of Stockholders’ equity were as follows for the periods indicated:
| Three months ended March 31
(Dollars in millions except per share data; shares in thousands) | Common stock |  | Additional paid-in capital |  | Retained earnings |  | Treasury stock |  | Accumulated other comprehensive net (loss) income |  | Noncontrolling interests |  | Total stockholders’ equity
Amount |  | Shares |  |  |  | Amount |  | Shares |  |  |
Balance as of December 31, 2024 | $ | 131 |  |  | 130,741 |  |  | $ | 1,287 |  |  | $ | 68 |  |  | $ | (1,346) |  |  | (7,591) |  |  | $ | (181) |  |  | $ | 162 |  |  | $ | 121 |
Net earnings | — |  |  | — |  |  | — |  |  | 186 |  |  | — |  |  | — |  |  | — |  |  | 5 |  |  | 191 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5 |  |  | — |  |  | 5 |
Dividends to Clorox stockholders ($1.22 per share declared) | — |  |  | — |  |  | — |  |  | (152) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (152) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4) |  |  | (4) |
Stock-based compensation | — |  |  | — |  |  | 24 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 24 |
Other employee stock plan activities | — |  |  | — |  |  | (7) |  |  | (3) |  |  | 15 |  |  | 101 |  |  | — |  |  | — |  |  | 5 |
Balance as of March 31, 2025 | $ | 131 |  |  | 130,741 |  |  | $ | 1,304 |  |  | $ | 99 |  |  | $ | (1,331) |  |  | (7,490) |  |  | $ | (176) |  |  | $ | 163 |  |  | $ | 190 |
Balance as of December 31, 2025 | $ | 131 |  |  | 130,741 |  |  | $ | 1,304 |  |  | $ | 190 |  |  | $ | (1,591) |  |  | (9,851) |  |  | $ | (159) |  |  | $ | 160 |  |  | $ | 35 |
Net earnings | — |  |  | — |  |  | — |  |  | 187 |  |  | — |  |  | — |  |  | — |  |  | 4 |  |  | 191 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 7 |  |  | — |  |  | 7 |
Dividends to Clorox stockholders ($1.24 per share declared) | — |  |  | — |  |  | — |  |  | (152) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (152) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (5) |  |  | (5) |
Stock-based compensation | — |  |  | — |  |  | 15 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 15 |
Other employee stock plan activities | — |  |  | — |  |  | (4) |  |  | (2) |  |  | 7 |  |  | 30 |  |  | — |  |  | — |  |  | 1 |
Balance as of March 31, 2026 | $ | 131 |  |  | 130,741 |  |  | $ | 1,315 |  |  | $ | 223 |  |  | $ | (1,584) |  |  | (9,821) |  |  | $ | (152) |  |  | $ | 159 |  |  | $ | 92 |
| Nine months ended March 31
(Dollars in millions except per share data; shares in thousands) | Common stock |  | Additional paid-in capital |  | Retained earnings |  | Treasury stock |  | Accumulated other comprehensive net (loss) income |  | Noncontrolling interests |  | Total stockholders’ equity
Amount |  | Shares |  |  |  | Amount |  | Shares |  |  |
Balance as of June 30, 2024 | $ | 131 |  |  | 130,741 |  |  | $ | 1,288 |  |  | $ | 250 |  |  | $ | (1,186) |  |  | (6,540) |  |  | $ | (155) |  |  | $ | 164 |  |  | $ | 492 |
Net earnings | — |  |  | — |  |  | — |  |  | 478 |  |  | — |  |  | — |  |  | — |  |  | 10 |  |  | 488 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (21) |  |  | — |  |  | (21) |
Dividends to Clorox stockholders ($4.88 per share declared) | — |  |  | — |  |  | — |  |  | (609) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (609) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (11) |  |  | (11) |
Stock-based compensation | — |  |  | — |  |  | 64 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 64 |
Other employee stock plan activities | — |  |  | — |  |  | (48) |  |  | (20) |  |  | 112 |  |  | 745 |  |  | — |  |  | — |  |  | 44 |
Treasury stock purchased | — |  |  | — |  |  | — |  |  | — |  |  | (257) |  |  | (1,695) |  |  | — |  |  | — |  |  | (257) |
Balance as of March 31, 2025 | $ | 131 |  |  | 130,741 |  |  | $ | 1,304 |  |  | $ | 99 |  |  | $ | (1,331) |  |  | (7,490) |  |  | $ | (176) |  |  | $ | 163 |  |  | $ | 190 |
Balance as of June 30, 2025 | $ | 131 |  |  | 130,741 |  |  | $ | 1,319 |  |  | $ | 432 |  |  | $ | (1,404) |  |  | (8,047) |  |  | $ | (157) |  |  | $ | 161 |  |  | $ | 482 |
Net earnings | — |  |  | — |  |  | — |  |  | 424 |  |  | — |  |  | — |  |  | — |  |  | 10 |  |  | 434 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5 |  |  | — |  |  | 5 |
Dividends to Clorox stockholders ($4.96 per share declared) | — |  |  | — |  |  | — |  |  | (608) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (608) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (12) |  |  | (12) |
Stock-based compensation | — |  |  | — |  |  | 49 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 49 |
Other employee stock plan activities | — |  |  | — |  |  | (53) |  |  | (25) |  |  | 78 |  |  | 383 |  |  | — |  |  | — |  |  | — |
Treasury stock purchased | — |  |  | — |  |  | — |  |  | — |  |  | (258) |  |  | (2,157) |  |  | — |  |  | — |  |  | (258) |
Balance as of March 31, 2026 | $ | 131 |  |  | 130,741 |  |  | $ | 1,315 |  |  | $ | 223 |  |  | $ | (1,584) |  |  | (9,821) |  |  | $ | (152) |  |  | $ | 159 |  |  | $ | 92 |
Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:
| Three months ended March 31
| Foreign currency translation adjustments |  | Net unrealized gains (losses) on derivatives |  | Pension and postretirement benefit adjustments |  | Accumulated other comprehensive net (loss) income
Balance as of December 31, 2024 | $ | (259) |  |  | $ | 80 |  |  | $ | (2) |  |  | $ | (181) |
Other comprehensive (loss) income before reclassifications | 6 |  |  | — |  |  | — |  |  | 6 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | (2) |  |  | — |  |  | (2) |
Income tax benefit (expense) | 1 |  |  | — |  |  | — |  |  | 1 |
Net current period other comprehensive (loss) income | 7 |  |  | (2) |  |  | — |  |  | 5 |
Balance as of March 31, 2025 | $ | (252) |  |  | $ | 78 |  |  | $ | (2) |  |  | $ | (176) |
Balance as of December 31, 2025 | $ | (226) |  |  | $ | 69 |  |  | $ | (2) |  |  | $ | (159) |
Other comprehensive (loss) income before reclassifications | (4) |  |  | 19 |  |  | — |  |  | 15 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | (3) |  |  | — |  |  | (3) |
Income tax benefit (expense) | — |  |  | (5) |  |  | — |  |  | (5) |
Net current period other comprehensive (loss) income | (4) |  |  | 11 |  |  | — |  |  | 7 |
Balance as of March 31, 2026 | $ | (230) |  |  | $ | 80 |  |  | $ | (2) |  |  | $ | (152) |
| Nine months ended March 31
| Foreign currency translation adjustments |  | Net unrealized gains (losses) on derivatives |  | Pension and postretirement benefit adjustments |  | Accumulated other comprehensive net (loss) income
Balance as of June 30, 2024 | $ | (239) |  |  | $ | 85 |  |  | $ | (1) |  |  | $ | (155) |
Other comprehensive (loss) income before reclassifications | (14) |  |  | (1) |  |  | — |  |  | (15) |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | (5) |  |  | (1) |  |  | (6) |
Income tax benefit (expense) | 1 |  |  | (1) |  |  | — |  |  | — |
Net current period other comprehensive (loss) income | (13) |  |  | (7) |  |  | (1) |  |  | (21) |
Balance as of March 31, 2025 | $ | (252) |  |  | $ | 78 |  |  | $ | (2) |  |  | $ | (176) |
Balance as of June 30, 2025 | $ | (233) |  |  | $ | 77 |  |  | $ | (1) |  |  | $ | (157) |
Other comprehensive (loss) income before reclassifications | 2 |  |  | 18 |  |  | — |  |  | 20 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | (11) |  |  | (1) |  |  | (12) |
Income tax benefit (expense) | 1 |  |  | (4) |  |  | — |  |  | (3) |
Net current period other comprehensive (loss) income | 3 |  |  | 3 |  |  | (1) |  |  | 5 |
Balance as of March 31, 2026 | $ | (230) |  |  | $ | 80 |  |  | $ | (2) |  |  | $ | (152) |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration